Efficacy and safety of Symbicort (budesonide/ formoterol) 1280/36 mcg daily delivered dose compared to Pulmicort (budesonide) 1600 mcg metered dose and Pulmicort (budesonide) 1600 mcg metered dose plus Oxis (formoterol) 36 mcg delivered dose all delivered via Turbuhaler in steroid-using asthmatic adolescents and adults. A double-blind, double-dummy, randomized, parallel group, phase III, multicentre study.

Study identifier:SD-039-0689

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

Efficacy and safety of Symbicort (budesonide/ formoterol) 1280/36 mcg daily delivered dose compared to Pulmicort (budesonide) 1600 mcg metered dose and Pulmicort (budesonide) 1600 mcg metered dose plus Oxis (formoterol) 36 mcg delivered dose all delivered via Turbuhaler in steroid-using asthmatic adolescents and adults. A double-blind, double-dummy, randomized, parallel group, phase III, multicentre study.

Medical condition

asthma

Phase

Phase 3

Healthy volunteers

-

Study drug

-

Sex

-

Actual Enrollment

-

Study type

Interventional

Age

-

Date

Study Start Date: 01 Jul 2001
Primary Completion Date: -
Study Completion Date: -

Study design

Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Nov 2013 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria